{"id":"NCT02586805","sponsor":"Shire","briefTitle":"Efficacy and Safety Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE","officialTitle":"HELP Study: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study to Evaluate DX-2930 For Long-Term Prophylaxis Against Acute Attacks of Hereditary Angioedema (HAE)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-03-03","primaryCompletion":"2017-04-13","completion":"2017-04-13","firstPosted":"2015-10-26","resultsPosted":"2018-04-24","lastUpdate":"2021-06-02"},"enrollment":125,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Hereditary Angioedema (HAE)"],"interventions":[{"type":"DRUG","name":"DX-2930 - 300mg/2wk","otherNames":[]},{"type":"DRUG","name":"DX-2930 - 300mg/4wk","otherNames":[]},{"type":"DRUG","name":"DX-2930 - 150mg/4wk","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"DX-2930 300 mg every 2 weeks","type":"EXPERIMENTAL"},{"label":"DX-2930 300 mg every 4 weeks","type":"EXPERIMENTAL"},{"label":"DX-2930 150 mg every 4 weeks","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This is a phase 3, multicenter, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of DX-2930 in preventing acute angioedema attacks in patients with Type I and Type II HAE.","primaryOutcome":{"measure":"Rate of Investigator Confirmed Hereditary Angioedema (HAE) Attacks During Treatment Period","timeFrame":"From Day 0 to Day 182","effectByArm":[{"arm":"Placebo","deltaMin":1.967,"sd":null},{"arm":"Lanadelumab (DX-2930) 150 mg Every 4 Weeks","deltaMin":0.48,"sd":null},{"arm":"Lanadelumab (DX-2930) 300 mg Every 4 Weeks","deltaMin":0.526,"sd":null},{"arm":"Lanadelumab (DX-2930) 300 mg Every 2 Weeks","deltaMin":0.257,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"},{"comp":"OG000 vs OG002","p":"<0.001"},{"comp":"OG000 vs OG003","p":"<0.001"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":9},"locations":{"siteCount":41,"countries":["United States","Canada","Germany","Italy","Jordan","Puerto Rico","United Kingdom"]},"refs":{"pmids":["37028510","36326435","36153561","30480729"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":41},"commonTop":["Hereditary angioedema","Injection site pain","Viral upper respiratory tract infection","Headache","Injection site erythema"]}}